This is my second time trying GLP-1s, and it's been an awesome and smooth ride
Others simply accept the minor loss
Opportunity Pathways - GLP-1 Diabetes Treatment Drugs Market The GLP-1 diabetes treatment drugs market represents one of the most explosive pharmaceutical opportunities of the decade, with the market projected to surge from USD 6,556.5 million in 2025 to USD 62,543.2 million by 2035 at an extraordinary 25.3% CAGRa 9.5X expansion driven by the global diabetes epidemic, breakthrough efficacy data, and expanding therapeutic applications beyond glucose control to include weight management and cardiovascular protection
Plasma PYY 336 concentrations rise within 15 min of food ingestion, well before nutrients reach the colon or rectum where it is released, implicating a neural or hormonal mechanism for its release [9]
Even when thyroid-stimulating hormone (TSH) is normalized with levothyroxine, residual metabolic dysfunction and appetite dysregulation can persist, making traditional calorie restriction less effective for some patients
